PERITONEAL NEOPLASMS
Clinical trials for PERITONEAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL NEOPLASMS trials appear
Sign up with your email to follow new studies for PERITONEAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in ovarian cancer fight
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab (Keytruda) and the targeted therapy olaparib (Lynparza) to standard chemotherapy helps women with advanced ovarian, fallopian tube, or primary peritoneal cancer that does not have a BRCA mutation. Over 1,300 pa…
Matched conditions: PERITONEAL NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 06:39 UTC
-
Protein fingerprint may predict ovarian cancer relapse
Knowledge-focused CompletedThis study aimed to create a blood test that could predict when ovarian, peritoneal, or fallopian tube cancer might come back. Researchers looked for specific protein patterns, called a 'fingerprint,' in the blood of 119 women whose cancer was in remission. Participants had regul…
Matched conditions: PERITONEAL NEOPLASMS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 06:23 UTC